Watch this webinar exploring real challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases to support clinical development through commercial post-approval.
Inspire, the leading patient engagement and real-world evidence platform, brings together industry experts Megan Gower, PharmD and Edward Chou, PhD at Takeda who share their expertise, experiences, and lessons learned in this field.
Rare diseases pose unique challenges when it comes to generating robust and reliable evidence due to their low prevalence and limited available data. However, patient-centered RWE is increasingly important at every phase of drug development and post approval marketing. During this webinar, industry experts discuss challenges and potential solutions for collecting, analyzing, and interpreting patient-centered real-world data.
Key Topics Include:
- Understand common challenges associated with access to rare disease patients necessary for generating patient-centered real-world evidence.
- Learn about best practices to ensure high quality real-world data, including methodologies and innovative strategies for data collection and analysis.
- Discover the benefits of patient engagement and collaboration in enhancing real-world evidence generation.
Presenters
Clinical Scientist
Takeda US Medical Value and Evidence Generation Clinical Research
Takeda
Associate Director
Takeda US Medical Value and Evidence Generation Health Economics and Outcomes Research
Takeda
Senior Vice President
Real World Evidence
Inspire
Production Partner
Inspire
